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Abstract 
We previously demonstrated that the opioid peptide, enkephalin, and corticotropin-
releasing factor (CRF) are occasionally co-localized in individual axon terminals but 
more frequently converge on common dendrites in the locus coeruleus (LC). To further 
examine potential opioid co-transmitters in CRF afferents, we investigated the 
distribution of proopiomelanocortin (POMC), the precursor that yields the potent 
bioactive peptide, -endorphin, with respect to CRF immunoreactivity using 
immunofluorescence and immunoelectron microscopic analyses of the LC. Coronal 
sections were collected through the dorsal pontine tegmentum of rat brain and processed 
for immunocytochemical detection of POMC and CRF or tyrosine hydroxylase (TH). 
POMC-immunoreactive processes exhibited a distinct distribution within the LC as 
compared to the enkephalin family of opioid peptides. Specifically, POMC fibers were 
enriched in the ventromedial aspect of the LC with fewer fibers present dorsolaterally. 
Immunofluorescence microscopy showed frequent co-existence of POMC and CRF in 
varicose processes that overlapped TH-containing somatodendritic processes in the LC. 
Ultrastructural analysis showed POMC immunoreactivity in unmyelinated axons and 
axon terminals. Axon terminals containing POMC were filled with numerous large dense 
core vesicles. In sections processed for POMC and TH, approximately 29% of POMC-
containing axon terminals (n = 405) targeted dendrites that exhibited immunogold-silver 
labeling for TH. Whereas, sections processed for POMC and CRF showed that 27% of 
POMC-labeled axon terminals (n = 657) also exhibited CRF immunoreactivity. Taken 
together, these data indicate that a subset of CRF afferents targeting the LC contain 
POMC and may be positioned to dually impact LC activity.  
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Introduction 
 We have previously demonstrated that corticotropin-releasing factor (CRF) and 
endogenous opioids interact in the locus coeruleus (LC) to modulate noradrenergic 
function (Valentino et al., 1992; Van Bockstaele et al., 1996a; Van Bockstaele et al.,
1996b; Xu et al., 2004). Specifically, we showed that chronic morphine administration 
sensitized the LC neurons to CRF (Xu et al., 2004). In an effort to further elucidate 
interactions between CRF and opioid associated with peptides that modulate mu-opioid 
receptors, we examined here the distribution of proopiomelanocortin (POMC), an opioid 
precursor, and CRF in this noradrenergic nucleus. 
POMC is processed to yield the potent bioactive peptide, F-endorphin, which is 
associated with stress regulation (Baubet et al., 1994). -endorphin interacts with µ-
opioid receptors to mediate stress-induced analgesia (Rubinstein et al., 1996) and it has 
been implicated in nociception (Foley et al., 1979; Yaksh et al., 1982; Bertolini et al.,
1986; Baubet et al., 1994). In the present study, the ultrastructural distribution of POMC 
and catecholamine-containing neurons in the LC that may likely underlie the effects of 
POMC were investigated using immunofluorescence and electron microscopy in the rat 
brain. 
Previous studies suggest that the LC is densely innervated by processes exhibiting 
endogenous opioid peptides including leucine- and methionine-enkephalin (Drolet et al.,
1992; Van Bockstaele et al., 1995; Van Bockstaele et al., 1996c; Van Bockstaele & 
Chan, 1997; Van Bockstaele et al., 2000), F-endorphin (Bloom et al., 1978a; Bloom et 
al., 1978b), and dynorphin (Fallon & Leslie, 1986). Likewise, LC neurons demonstrate a 
high concentration of opioid receptors including µ-opioid receptors (Tempel & Zukin, 
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1987; Mansour et al., 1994; Mansour et al., 1995; Van Bockstaele et al., 1996a; Van 
Bockstaele et al., 1996b). 
Known for its population of noradrenergic neurons, the LC projects throughout all 
levels of the neuroaxis (Foote et al., 1983). Thus, LC neurons serve as the prime source 
of NE in the forebrain (Aston-Jones et al., 1985; McCormick et al., 1991). 
Electrophysiological and pharmacological studies showed a critical role of noradrenergic 
projections from the LC in the control of vigilance, attention and adaptive behavioral 
responses (Aston-Jones & Bloom, 1981b; a; Aston-Jones et al., 1984; Aston-Jones et al.,
1994) . In fact, LC neurons exhibit the highest firing rates during waking and decreased 
activity during slow-wave sleep, and are nearly quiescent during paradoxical sleep 
(Aston-Jones & Bloom, 1981a). Moreover, LC neurons respond to autonomic influences 
(Svensson, 1987) and are implicated in multiple autonomic functions (Morilak et al.,
1987a; b; Miyawaki et al., 1991). Afferents that innervate LC neurons can remarkably 
influence the neural circuitry involved in the diversity of functions ascribed to the LC 
(Aston-Jones et al., 1991). 
Corticotropin-releasing factor (CRF), the hypothalamic neurohormone that 
initiates the adrenocorticotropin release through its actions on corticotrophs of the 
adenohypophysis (Vale et al., 1981; Cummings et al., 1983; Swanson et al., 1983), also 
acts as a neurotransmitter in extrahypophyseal circuits that mediate behavioral and 
autonomic responses to stressors. Anatomical studies have described CRF-
immunoreactive fibers in noradrenergic LC neurons (Cummings et al., 1983; Swanson et 
al., 1983). Specifically, CRF-axon terminals target noradrenergic dendrites in the LC 
(Van Bockstaele et al., 1996d; Van Bockstaele et al., 1998b). In support of these data, 
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physiological studies have shown that CRF administration intracerebroventricularly or by 
microinfusion into the LC activated LC neurons (Valentino et al., 1983; Curtis et al.,
1997). In addition, CRF central administration or microinfusion into the LC increases NE 
levels in prefrontal cortex, a region which derives NE solely from the LC (Lavicky & 
Dunn, 1993; Smagin et al., 1995).  
Anatomically, medullary afferents to the LC originate from the nucleus of the 
solitary tract (NTS; (Van Bockstaele et al., 1998a; Van Bockstaele et al., 1999) that 
provides monosynaptic input to noradrenergic dendrites in the LC (Van Bockstaele et al.,
1999) . Additionally, immunohistochemical and biochemical analyses have shown 
POMC (Schwartzberg & Nakane, 1982) and CRF (Herbert & Saper, 1990) containing 
cell bodies within the NTS. Taken together with the important role of these neuropeptides 
in stress regulation (Baubet et al., 1994; Rubinstein et al., 1996; Vale et al., 1981;
Cummings et al., 1983; Swanson et al., 1983), it is important to elucidate the role of 
POMC afferents that may express CRF as a co-transmitter in the regulation of 
noradrenergic function. 
Materials and Methods 
Tissue preparation  
Ten adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN, 
USA) weighing 225-250 g were used for this study.  Five rats were used for examining 
the cellular associations of POMC with tyrosine hydroxylase- (TH) or CRF-containing 
cellular profiles in the dorsal pontine tegmentum using immunofluorescence while five 
rats were used for examining cellular associations using electron microscopy. The rats 
were housed 2-3 per cage on a 12-h light schedule in a temperature controlled (20 ºC) 
Reyes et al                                                          POMC and CRF co-localization in the LC 
 
6
colony room. They were given standard rat chow and water. The procedures were 
approved by the Institutional Animal Care and Use Committee of Thomas Jefferson 
University and conformed to NIH guidelines. All efforts were made to utilize only the 
minimum number of animals necessary to produce reliable scientific data and attempts 
were made to minimize animal suffering. 
Immunofluorescence microscopy 
Rats were deeply anesthetized with sodium pentobarbital (60 mg/kg) and 
transcardially perfused through the ascending aorta with 500 ml of 4% formaldehyde in 
0.1 M phosphate buffer (PB; pH 7.4). Brains were then removed and post fixed in 4% 
formaldehyde overnight at 4°C. Forty micrometer thick sections through the LC were cut 
with a Vibratome (Technical Product International, St Louis, MO, USA) and rinsed 
extensively in 0.1 M PB and 0.1 M tris-buffered saline (TBS; pH 7.6). Sections were 
placed for 30 min in 1% sodium borohydride in 0.1 M PB to remove reactive aldehydes 
and incubated in 0.5% bovine serum albumin (BSA) in 0.1M TBS for 30 min. 
Subsequently, sections were then incubated in 0.5% bovine serum albumin (BSA) and 
0.25% Triton X-100 in 0.1M TBS for 30 min and rinsed extensively in 0.1 M TBS. 
Subsequently, sections were processed for POMC and TH or POMC and CRF 
immunoreactivities.  
Sections processed for POMC and TH were incubated in a cocktail containing 
rabbit anti-POMC (Phoenix Pharmaceuticals Inc., Belmont, CA, USA) at 1:5,000 and 
mouse anti-TH (Immunostar Inc., Hudson, WI, USA) at 1:1,000. Incubation time was 15-
18 h in a rotary shaker at room temperature. The antiserum to POMC (27-52 amino acid 
sequence) was generated in rabbits against porcine POMC. The specificity of the mouse 
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antiserum against TH was previously decribed (Van Bockstaele & Pickel, 1993) and it 
specifically recognizes the catecholamine synthesizing enzyme. 
Sections were then washed in 0.1 M TBS and incubated in a secondary antibody 
cocktail containing flourescein isothiocyanate (FITC) goat-anti-rabbit (1:100; Jackson 
ImmunoResearch Laboratories Inc., West Grove, PA, USA) and tetramethyl rhodamine 
isothiocyanate (TRITC) donkey anti-mouse (1:100; Jackson ImmunoResearch) prepared 
in 0.1 % BSA and 0.25% Triton X-100 in 0.1 M TBS for 2 h in the dark on a rotary 
shaker.  
Sections processed for POMC and CRF were incubated in a cocktail containing 
rabbit anti-POMC at 1:5,000 and guinea pig anti-CRF (Peninsula Pharmaceuticals Inc., 
Belmont, CA, USA) at 1:1,000. Incubation time was 15-18 h in a rotary shaker at room 
temperature. The antiserum to CRF was raised in guinea pig and recognizes human and 
rat CRF. Sections were then washed in 0.1 M TBS and incubated in a secondary antibody 
cocktail containing FITC goat-anti-rabbit (1:100; Jackson ImmunoResearch Laboratories 
Inc.) and TRITC donkey anti-guinea pig (1:100; Jackson ImmunoResearch Laboratories 
Inc.) prepared in 0.1 % BSA and 0.25% Triton X-100 in 0.1 M TBS for 2 h in the dark on 
a rotary shaker.  
Following incubation with the secondary antibodies, the tissues were washed 
thoroughly in 0.1 M TBS. Afterwards, the tissues were mounted on slides and allowed to 
dry in complete darkness. The slides were then dehydrated in a series of alcohols, soaked 
in xylene and coverslipped using DPX (Sigma-Aldrich Inc., St. Louis, MO, USA). A 
confocal microscope (Zeiss LSM 510 Meta, Carl Zeiss Inc., Thornwood, NY, USA) was 
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used to visualize the immunofluorescence labeling and digital images were obtained and 
imported using the LSM 5 image browser (Carl Zeiss Inc.). 
Immunoelectron microscopy  
The rats were deeply anesthetized with sodium pentobarbital (60 mg/kg) and 
perfused transcardially  through the ascending aorta with (1) 10 ml heparinized saline, (2) 
50 ml of 3.75% acrolein (Electron Microscopy Sciences, Fort Washington, PA, USA), 
and 200 ml of 2% formaldehyde in 0.1 M PB, ph 7.4. Immediately after perfusion 
fixation, the brains were removed, sectioned into coronal slices and postfixed in the same 
fixative overnight at 4ºC. 
Alternate 40-µm thick sections through the rostrocaudal extent of the LC were 
processed for electron microscopic analysis of POMC and TH or POMC and CRF in the 
same section. Immunoperoxidase labeling was used to identify POMC immunoreactivity 
in sections processed for POMC and TH while immunoperoxidase labeling was used to 
identify CRF immunoreactivity for sections processed for POMC and CRF. Sections 
containing the LC were placed for 30 min in 1% sodium brohydride in 0.1 M PB and 
collected into 0.1 M PB to remove reactive aldehydes. Then sections were rinsed 
extensively in 0.1 M PB and incubated in 0.5% BSA in 0.1 M TBS for 30 min followed 
by several rinses in 0.1 M TBS. Tissue sections were incubated in primary antibody 
cocktail of rabbit anti-POMC (1:5000) and mouse anti-TH (1:1,000) for 15-18 h at room 
temperature. The following day, sections were rinsed three times in 0.1 M TBS 
andincubated in biotinylated donkey anti-rabbit (1:400; Jackson ImmunoResearch 
Laboratories, Inc.) for 30 min followed by rinses in 0.1 M TBS. Subsequently, a 30-
minute incubation of avidin-biotin complex (Vector Laboratories, Burlingame, CA, USA) 
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followed. For all incubations and washes, sections were continuously agitated with a 
rotary shaker. POMC was visualized by a 9-minute reaction in 22 mg of 3,3’-
diaminobenzidine (Sigma-Aldrich Inc.) and 10 Ol of 30% hydrogen peroxide in 100 ml of 
0.1 M TBS. Some sections were collected, dehydrated and coverslipped for light 
microscopic analysis of POMC immunoreactivity. 
For gold-silver localization of TH (in sections processed for POMC and TH) and 
POMC (in sections processed for POMC and CRF), sections were rinsed three times with 
0.1 M TBS, followed by rinses with 0.1 M PB and 0.01 phosphate buffered saline (PBS; 
pH 7.4). Sections were then incubated in a 0.2% gelatin-PBS and 0.8% BSA buffer for 10 
min. This was followed by incubation in either goat anti-mouse IgG conjugate in 1 nm 
gold particles (Amersham Bioscience Corp., Piscataway, NJ, USA) for TH or goat anti-
rabbit IgG conjugate in 1 nm gold particles (Amersham Bioscience Corp.) at room 
temperature for 2 h. Sections were then rinsed in buffer containing the same 
concentration of gelatin and BSA as above and subsequently rinsed with 0.01 M PBS. 
Sections were then incubated in 2% glutaraldehyde (Electron Microscopy Sciences) in 
0.01 M PBS for 10 min followed by washes in 0.01 M PBS and 0.2 M sodium citrate 
buffer (pH 7.4). A silver enhancement kit (Amersham Bioscience Corp.) was used for 
silver intensification of the gold particles. The optimal times for silver enhancement time 
were determined by empirical observation for each experiment and ranged 10-15 min. 
Following intensification, tissues were rinsed in 0.2 M citrate buffer and 0.1 M PB, and 
incubated in 2% osmium tetroxide (Electron Microscopy Sciences) in 0.1 M PB for 1 h, 
washed in 0.1 M PB, dehydrated in an ascending series of ethanol followed by propylene 
oxide and flat embedded in Epon 812 (Electron Microscopy Sciences; Leranth and 
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Pickel, 1989). Thin sections of approximately 50-100 nm in thickness were cut with a 
diamond knife (Diatome-US, Fort Washington, PA, USA) using a Leica Ultracut (Leica 
Microsystems, Wetzlar, Germany). Sections were collected on copper mesh grids, 
examined with an electron microscope (Morgagni, Fei Company, Hillsboro,OR, USA) 
and digital images were captured using the AMT advantage HR/HR-B CCD camera 
system (Advance Microscopy Techniques Corp., Danvers, MA, USA). Figures were 
assembled and adjusted for brightness and contrast in Adobe Photoshop. 
Control and data analysis 
Tissue sections for electron microscopy were taken from rats with the best 
immunocytochemical labeling and preservation of ultrastructural morphology. The 
quantitative approach used in the present study is well established and has been described 
previously (Van Bockstaele et al., 1996a; Van Bockstaele et al., 1996d; Van Bockstaele 
et al., 1998a). Control sections were run in parallel in which one of the primary antisera 
was omitted but the rest of the processing procedure was identical. Sections processed in 
the absence of primary antibody did not exhibit immunoreactivity. The region of the LC 
selected for electron microscopic analysis is shown in Figure 1A. For quantification of 
labeled profiles in 40 µm-thick sections immunolabeled before embedding for electron 
microscopy, we have observed that the collection of sections only from the surface of the 
section minimizes artifacts that may be associated with incomplete penetration of 
antisera. The analysis of tissue sections collected at the plastic-tissue interface ensured 
that both markers were detectable in all sections used for analysis (Chan et al., 1990). 
The cellular elements were identified based on the description of Peters and colleagues 
(Peters & Palay, 1996; Peters et al., 1991). Somata contained a nucleus, Golgi apparatus 
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and smooth endoplasmic reticulum. Proximal dendrites contained endoplasmic reticulum, 
were postsynaptic to axon terminals and were larger than 0.7 µm in diameter.  A terminal 
was considered to form a synapse if it showed a junctional complex, a restricted zone of 
parallel membranes with slight enlargement of the intercellular space, and/or associated 
with postsynaptic thickening. Asymmetric synapses were identified by thick postsynaptic 
densities (Gray’s type I; (Gray et al., 1959), in contrast, symmetric synapses had thin 
densities (Gray’s type II; (Gray et al., 1959) both pre- and postsynaptically. A non-
synaptic contact or apposition was defined as an axon terminal plasma membrane 
juxtaposed to that of a dendrite or soma devoid of recognizable membrane specializations 
and no intervening glial processes.  
In sections dually labeled for POMC and TH, the number of POMC axons and 
axon terminals was grouped from randomly selected sections from ultrathin sections 
taken from four nonadjacent sections from each animal (n = 5). At least four sections 
were examined per animal. From the surface of the individual epon block containing the 
tissue, at least four to eight ultrathin sections were collected. Fields of at least 11,000X 
magnification showing POMC-labeled axons and axon terminals, and TH-labeled profiles 
were captured and classified. This approach resulted in 405 POMC-labeled profiles. All 
potential neuronal targets of POMC-labeled axon terminals throughout the analysis were 
examined by defining their total associations with other profiles regardless of whether a 
membrane specialization was seen within the plane of section. These associations 
consisted of close appositions of neuronal plasma membranes not separated by glial 
processes. These profiles were considered since opioids as well as other peptides are 
released by exocytosis from nonsynaptic portions of plasmalemma (Thureson-Klein et 
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al., 1986; Zhu et al., 1986; Karhunen et al., 2001). Postsynaptic targets considered 
included dendrites containing gold-silver labeling for TH, dendrites lacking gold-silver 
labeling for TH, unlabeled terminals and glial processes. POMC-labeled profiles forming 
clear synaptic specializations were classified as symmetric (Gray’s Type II) or 
asymmetric (Gray’s Type I). On the other hand, undefined contacts were characterized by 
a junctional complex that was not readily identifiable.  
 In sections dually labeled for POMC and CRF, POMC axons and axon terminals 
were studied from fields of at least 11,000X magnification found in at least four ultrathin 
sections  taken from four sections from each animal (n = 5). Fields showing POMC- 
labeled axons and axon terminals and CRF-labeled neuropil were captured and classified. 
This approach resulted in 657 POMC-labeled profiles.  
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Results 
By light microscopy, the LC was visualized using an antibody directed against 
POMC and appeared as dense immunoreactive processes distributed in the ventromedial 
aspect of the LC in the rostral pons (Fig. 1A). Fewer POMC-labeled fibers were found 
dorsolaterally. Immunofluorescence labeling for POMC and TH was visualized in 
coronal sections of the LC (Figs 1C-D). Immunocytochemical labeling for TH at rostral 
pontine levels showed considerable TH-immunoreactive dendrites extending from somata 
in the LC, medial and ventral to the fourth ventricle (Fig. 1B-D) consistent with previous 
studies (Van Bockstaele et al., 1995; Shipley et al., 1996). At caudal levels, TH- 
immunoreactive dendrites of the peri-LC area, immediately medial to the core of LC 
neurons, was evidently less dense than that of the rostral levels (not shown). Conversely, 
the core of the LC exhibited a dense population of TH-immunoreactive somata (Fig. 1B 
and D). Immunocytochemical labeling for POMC revealed varicose processes within the 
peri-LC at rostral levels (Figs 1B-D). Numerous POMC-immunoreactive processes 
extended into the core of the LC where the somata of LC neurons are found (Figs 1B and 
D). POMC-immunoreactive fibers were morphologically heterogeneous. Some fibers 
were thin and beaded while others were thicker and lacked varicosities (Figs 1B-D). 
Ultrastructural analysis of POMC and TH 
At the electron microscopic level, immunoperoxidase labeling for POMC and 
immunogold-silver labeling for TH were localized within single sections of the LC. 
POMC immunoreactivity was identified primarily in unmyelinated axon terminals (Fig. 
2). POMC-labeled dense core vesicles could be identified adjacent to the plasmalemma 
most commonly apposed to astrocytic process (Fig. 2A). Morever, POMC-labeled axon 
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terminals contained abundant small clear spherical vesicles (Figs 2A-C). Often, 
peroxidase labeling for POMC rimmed the membranes of small clear spherical vesicles 
(Figs 2A-B). Large dense core vesicles were observed in POMC-labeled terminals (Figs 
2 & D) and contained abundant peroxidase labeling. TH-immunoreactivity was primarily 
localized to somatodendritic processes (Figs 2C-D), although occasionally axon terminals 
exhibited gold-silver labeling for TH.  
POMC-labeled axon terminals showed synaptic specializations with TH-labeled 
and -unlabeled dendrites (Figs 2B-C). Semiquantitative analysis revealed that POMC-
labeled axon terminals frequently contacted TH-labeled dendrites (29%; n = 118). When 
synaptic specializations were identifiable, they were either of the symmetric, inhibitory 
type (Gray’s type; Gray, 1959) or the asymmetric, excitatory type. Some of the POMC-
labeled axon terminals did not form clearly defined synaptic specializations with 
postsynaptic targets in the single planes of section analyzed (Fig. 2C). Of the 118 POMC-
labeled axon terminals that were in direct contact with TH-labeled dendrites, 39% 
(46/118) were of the symmetric type while 18% (21/118) were asymmetric. The 
remainder did not form well defined synapses in the plane of sections analyzed. 
Approximately, 15% of the POMC-labeled axon terminals were occasionally apposed to 
other axon terminals. Frequently, appositions with other terminals lacked the specialized 
densities characteristic of axo-axonic synapses. 
Cellular interactions between POMC and CRF 
Immunofluorescence labeling for POMC and CRF was visualized in coronal 
sections in the rostral pontine tegmentum (Figs 3A-C). Immunocytochemical labeling for 
POMC and CRF exhibited a punctate pattern of staining and densely labeled fibers (Figs 
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3A-C). POMC immunoreactivity was localized to CRF-labeled processes and this was 
more prominent in the peri-LC as compared to the core region (Fig. 3C). 
Ultrastructural analysis of POMC and CRF 
At the ultrastructural level, POMC immunolabeling showed a similar distribution 
as described above (Figs 4 and 5). CRF immunoreactivity was restricted to axons and 
axon terminals and was rarely seen in somata and dendrites consistent with previous 
findings (Van Bockstaele et al., 1996d; Van Bockstaele et al., 1998b). Of 657 POMC-
labeled axon terminals, where CRF immunoreactivity was present in the neuropil, 27% 
(178/657) contained CRF immunoreactivity. Conversely, of 542 CRF-labeled terminals 
where POMC immunoreactivity was present in the neuropil, 33% (178/542) were dually 
labeled. The dually-labeled terminals contained several recognizable small clear vesicles 
and one or more mitochondria (Figs 4A-D). Some of these also contained large dense 
core vesicles (Figs 4A-C). The dually-labeled axon terminals contacted primarily 
medium to small sized dendrites. Some of these terminals did not form recognizable 
synaptic specializations in the single planes of section analyzed. However, when synaptic 
specializations were recognizable, they were more frequently of the asymmetric type 
(Figs 4A, 4C and 5A-B). Of 178 POMC-labeled axon terminals that contained CRF 
immunoreactivity, 29% and 21% formed asymmetric and symmetric synapses (Figs 4D 
and 5C), respectively. The remainder did not form identifiable synapses in sections 
examined.  
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Discussion 
The present findings demonstrate the first ultrastructural evidence that POMC-
immunoreactive axon terminals form synaptic specializations with TH-containing 
dendrites in the LC. In addition, results show that POMC and CRF co-exist in single axon 
terminals in the LC. These data provide a neuroanatomical substrate whereby CRF 
afferents containing POMC derived peptides, such as -endorphin, are positioned to 
impact the LC-NE system. This substrate could underlie activation of the brain NE 
system by stress and may serve to integrate autonomic components of the stress response 
associated with functions of LC neurons. 
The present results provide the first ultrastructural description of POMC-labeled 
fibers in the rat LC. POMC fibers have been demonstrated in the LC in aquatic toad 
(Tuinhof et al., 1998). Our findings of the POMC distribution in the LC are consistent 
with that of -endorphin, a peptide synthesized from POMC described in earlier studies, 
(Bloom et al., 1978a) where fibers course toward the middle third of the LC in the 
ventromedial aspect but are scant at caudal levels. By using dual immunoelectron 
microscopy, we provide the first ultrastructural evidence that POMC fibers form synaptic 
specializations with catecholamine-containing dendrites in the LC. In addition, we 
demonstrate that POMC-labeled fibers form primarily symmetric synapses that are 
correlated with inhibitory transmission, with TH-labeled dendrites in the LC (Peters & 
Palay, 1996; Peters et al., 1991). 
-endorphin influences nociception  (Foley et al., 1979; Yaksh et al., 1982;
Bertolini et al., 1986; Baubet et al., 1994), cardiovascular (Laubie et al., 1977; Holaday, 
1983), respiratory (Moss & Friedman, 1978) and stress responses (Baubet et al., 1994). 
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As such, intracoerulear injections of -endorphin suppressed long lasting posture 
asymmetry and movement (Bertolini et al., 1986) and significantly elevated nociceptive 
threshold (Yaksh et al., 1982) which were reversed by naloxone, an opioid antagonist. In 
addition, -endorphin administration via the cisterna magna caused a transient increase in 
blood pressure and heart rate followed by a delayed hypotension and bradycardia (Laubie 
et al., 1977). Loh and colleagues (Loh et al., 1976) demonstrated that -endorphin 
inhibits striatal dopamine release in vitro. Furthermore, in situ hybridization study 
showed that acute stress increased POMC mRNA expression in the mediobasal 
hypothalamus (Baubet et al., 1994). Our present findings indicate that POMC modulates 
LC neurons directly in the dorsal pontine tegmentum. Hence, the central effects of -
endorphin described earlier may represent actions of this potent peptide on LC neurons as 
these neurons are engaged in similar activities. 
Previous studies have shown that the arcuate nucleus (ARC) and NTS are 
enriched with POMC-immunoreactive perikarya (Schwartzberg & Nakane, 1982; Gee et 
al., 1983). ARC and NTS are brain regions involved in a myriad of autonomic functions 
such as cardiovascular (Lu et al., 2002; Weston et al., 2003; Balan Junior et al., 2004;
Guo & Moazzami, 2004), nociception (Sun & Yu, 2005; Tonosaki et al., 2005) and stress 
responses (Buller, 2003; Dayas et al., 2004; Helmreich et al., 2005; Kas et al., 2005;
Sergeyev et al., 2005). Similarly, LC neurons have been implicated in autonomic 
functions including cardiovascular, respiratory and stress responses (Aston-Jones et al.,
1991; Allen & Cechetto, 1992; Cechetto & Chen, 1992; Reis & Golanov, 1997; 
Valentino et al., 1998; Machado, 2001). POMC fibers in the LC may be derived from the 
ARC and NTS since anatomical studies using retrograde tracing revealed that neurons 
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from the ARC send projections to the LC (Luppi et al., 1995). In addition, we have 
previously demonstrated that efferent projections from the NTS monosynaptically 
innervate dendrites exhibiting TH-immunoreactivity in the rostral LC area where we 
found abundant POMC fibers (Van Bockstaele et al., 1999). The present study 
demonstrating dual-labeling for POMC-immunoreactive terminals and TH-
immunoreactive dendrites show that majority of the synapses identified were of 
symmetric type. These suggest that the ARC and NTS may be possible sources of POMC 
afferent fibers projecting to the LC that could regulate LC activity. 
In the present study, immunofluorescence showed prominent co-localization of 
POMC and CRF terminals in the ventromedial aspect of the LC. However, there was 
little evidence of POMC and CRF co-localization in the dorsolateral aspect of the LC. 
The anatomical distribution of POMC and CRF co-localization is in contrast to the 
distribution of fibers dually labeled for enkephalin and CRF in the LC (Tjoumakaris et 
al., 2003) which was visualized more in the LC core and some observed dorsolaterally. 
This was confirmed at the ultrastructural level, where POMC and CRF dually labeled 
terminals were located primarily in the ventromedial aspect of the LC. With regard to the 
degree of co-localization with enkephalin (12% of enkephalin terminals; Tjoumakaris et 
al., 2003), the percentage of POMC-labeled terminals that exhibited CRF 
immunoreactivity in this study was greater. Therefore, although many POMC and CRF 
terminals were singly labeled, this study also shows a distinct population of terminals that 
co-localized both peptides. 
The NTS is a potential source of POMC and CRF dually labeled terminals in the 
LC because it contains numerous CRF (Herbert & Saper, 1990) and POMC 
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(Schwartzberg & Nakane, 1982) neurons. Taken with our previous demonstration that 
NTS efferents form synaptic specializations with catecholaminergic LC dendrites (Van 
Bockstaele et al., 1999), it is tempting to speculate that CRF neurons in the NTS that co-
express -endorphin innervate LC neurons. Future studies would be useful to elucidate 
whether these terminals arise from the NTS.  
Our findings also show that POMC/CRF afferents containing axon terminals form 
asymmetric (29%) and symmetric (21%) synapses with postsynaptic targets. Asymmetric 
synapses have been correlated with excitatory transmission whereas symmetric synapses 
have been correlated with inhibitory transmission (Gray 1959; Carlin et al., 1980; Carlin 
et al., 1981; Peters et al., 1991; Peters et al., 1996). These data suggest that POMC/CRF 
afferents may originate from different afferent nuclei (ARC vs NTS) based on their 
morphological heterogeneity. In addition, the heterogeneous morphological 
differentiation of the synapses may indicate co-existence with either excitatory or 
inhibitory amino acid transmitter such as glutamate or gamma-aminobutyric acid 
(GABA). We have shown that CRF forms primarily asymmetric synapses with LC 
dendrites and that some of these contain glutamate (30%; Valentino et al., 2001). 
However, we also showed that some CRF terminals contain GABA (5%) suggesting that, 
in the present study POMC/CRF terminals may co-express distinct amino acid 
transmitters, and by the virtue of this, exhibit distinct synaptic specializations. Future 
studies are required to determine whether POMC/CRF terminals co-express different 
amino acid transmitters.  
In conclusion, our present results suggest that POMC is localized to efferents that 
target LC neurons, a circuit that may facilitate modulation of autonomic functions 
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including nociceptive, cardiovascular and respiratory functions. In addition, afferents 
expressing both CRF and POMC as co-transmitters may be involved in regulation of 
stress responses known to be subserved by this region.  
 
Abbreviations 
CRF, corticotropin-releasing factor; LC, locus coeruleus; POMC, proopiomelanocortin; 
TH, tyrosine hydroxylase;   
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Figure Legends 
 
Figure 1. A. Brightfield photomicrographs of proopiomelanocortin (POMC) in the locus 
coeruleus (LC). Arrows indicate individual POMC-labeled processes. Note that many are 
highly beaded and thin. Inset in panel A shows a schematic diagram adapted from the rat 
brain atlas of Swanson (1992) depicting the region sampled. In the inset, arrows indicate 
dorsal (D) and medial (M) orientation of the sections illustrated. B-D. Confocal 
fluorescence photomicrographs of POMC (arrowheads) labeled with fluorescein 
isothiocyanate (green) and tyrosine hydroxylase (TH; arrows) labeled with rhodamine 
isothiocyanate (red) in the LC. Abundant POMC-labeled processes are associated with 
TH-labeled dendrites (C). This association extends into the LC somatic region (B and D). 
Scale bars, 100 µm. Abbreviations: scp, superior cerebellar peduncle; D, dorsal; IV, 
fourth ventricle; M, medial; mlf, medial longitudinal fasciculus; moV, motor root of the 
trigeminal nucleus; V, motor nucleus of the trigeminal nucleus. 
Figure 2. Electron photomicrographs showing peroxidase labeling for 
proopiomelanocortin (POMC) and gold-silver labeling for tyrosine hydroxylase (TH) in 
the locus coeruleus (LC). A. Peroxidase labeling can be seen in a POMC-labeled terminal 
(POMC-t) that contains dense core vesicles (dcv). Several unlabeled terminals (ut) that 
contain unlabeled dense core vesicles (udcv) can be seen in the neuropil. B. A
peroxidase-labeled POMC-t forms a symmetric synapse (arrow) with an unlabeled 
dendrite (ud). C. A peroxidase-labeled POMC-t that contains dcv is directly contacted 
(double arrow) with a TH-labeled dendrite (TH). Arrowheads indicate gold-silver 
labeling for TH. Arrows point to symmetric synapses formed by unlabeled terminals (ut). 
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D. Another peroxidase-labeled POMC-t forms a symmetric synapse (arrow) with a TH-d. 
Scale bars, 0.50 µm. ma, myelinated axon. 
Figure 3. Confocal fluorescence photomicrographs showing co-localization of 
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) in the locus 
coeruleus (LC). A and A1. CRF-labeling was detected by rhodamine isothiocyanate 
(red). Arrows point to individual CRF-labeled varicose processes that contain POMC. 
Arrowheads point to varicose processes that contain CRF. B and B1. POMC-labeling 
was detected by fluorescein isothiocyanate (green). Arrows point to individual POMC-
labeled varicose processes that contain CRF. Arrowheads point to varicose processes 
that contain POMC. C and C1. Merged image. Arrows point to POMC- and CRF-dual 
labeled varicose processes. Arrowheads point to either POMC or CRF varicose 
processes. Scale bars, 100 µm. 
Figure 4. Electron photomicrographs showing convergence and co-existence of 
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) in the locus 
coeruleus (LC). A. A gold-silver labeled (arrowheads) POMC terminal (POMC-t) and 
peroxidase-labeled CRF axon terminal (CRF-t) synapse (curved arrows) with a common 
dendrite (d). Another peroxidase-labeled CRF-t can also be identified in the neuropil. B. 
Two axon terminals containing both peroxidase labeling for CRF and gold-silver labeling 
(arrowheads) for POMC contact (arrow) a dendrite (d). C-D. Axon terminals containing 
both peroxidase labeling for CRF and gold-silver labeling (arrowheads) for POMC 
(POMC + CRF-t) contact dendrites (d) in the LC. Scale bars, 0.5µm.  
Figure 5. Electron photomicrographs showing synaptic specializations formed by 
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) axon terminals in 
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the locus coeruleus (LC). A-B. Gold-silver labeling for POMC (arrowheads) and 
peroxidase-labeling for CRF (POMC+ CRF-t) can be found in axon terminal forming 
asymmetric synapses (arrows) with dendrites (d). C. A POMC+ CRF-t forms a 
symmetric synapse (curved arrow) with a dendrite (d). Scale bars, 0.5µm. 
 
